# AI in Clinical Decision Support: Evidence, Limits, and Liability > Healthcare · AI Course · MED-6 > Source: https://ibl.ai/solutions/medical-healthcare/course/ai-clinical-decision-support > Last updated: 2026-08-25 **Deploy clinical decision support responsibly — evidence grounding, automation bias, transparency obligations, and where liability actually lands.** ## The Short Answer **Clinical decision support risks automation bias — clinicians deferring to a recommendation they would otherwise question — and liability is unsettled. ibl.ai supports local validation and transparency because you own all the code and the data, so an organization can test performance on its own population rather than trusting a vendor's numbers.** On ibl.ai you own all the code and the data, run it model-agnostic across any LLM, and pay with no per-seat pricing — so you can deploy anywhere, from your own cloud to a fully air-gapped network. [Request Access](https://ibl.ai/contact) · [Explore Healthcare](https://ibl.ai/solutions/medical-healthcare) ## Course facts - **Level:** Advanced - **Duration:** 6 hours across 8 modules - **Format:** Cohort workshop with validation labs - **Modules:** 8 - **Catalog code:** MED-6 - **Frameworks covered:** FDA CDS guidance, ONC algorithm transparency, HIPAA, NIST AI RMF ## What is this course about? Clinical decision support sits closest to patient harm and carries the least settled liability. This course covers evidence grounding and citation to primary literature, automation bias as the central risk, algorithm transparency obligations, performance across patient populations, and local validation before deployment. ## Who is this course for? - Chief medical informatics officers - Clinical decision support committees - Physician and nursing leadership - Quality and patient safety officers ### What do I need before starting? - Clinical background or clinical informatics experience - Familiarity with your CDS governance ## What will I be able to do afterwards? - Distinguish clinical decision support from a regulated device - Ground recommendations in primary literature with citation - Recognize and mitigate automation bias - Assess performance across patient populations - Design local validation before any clinical deployment ## What does each module cover? ### Module 1 — What is clinical decision support, and where is the regulatory line? The boundary between decision support and a regulated medical device. _(45 min)_ **Objectives** - Define clinical decision support - Identify the regulatory boundary - Classify your intended use **Topics:** CDS definition · Regulatory boundary · Device classification · Use classification **Activity:** Classify three intended CDS uses against the regulatory boundary. ### Module 2 — How do you ground in primary literature? Evidence grounding with citation, so a clinician can check the basis for a recommendation. _(50 min)_ **Objectives** - Ground recommendations in primary literature - Cite so clinicians can verify - Handle areas where evidence is weak or conflicting **Topics:** Evidence grounding · Citation · Evidence quality · Conflicting evidence **Activity:** Ground a recommendation set in primary literature with verifiable citations. ### Module 3 — What is automation bias and why is it the central risk? The tendency to defer to a recommendation, which grows as the system becomes more reliable. _(50 min)_ **Objectives** - Explain automation bias mechanically - Recognize it in clinical workflows - Design interfaces that preserve clinical scrutiny **Topics:** Automation bias · Reliability paradox · Interface design · Scrutiny preservation **Activity:** Design an interface intervention aimed at preserving clinical scrutiny. ### Module 4 — What must you disclose about the algorithm? Transparency obligations to clinicians and the information they need to judge a recommendation. _(45 min)_ **Objectives** - Determine transparency obligations - Provide clinicians the information they need - Handle vendor confidentiality claims **Topics:** Transparency obligations · Clinician information needs · Vendor confidentiality · Source attributes **Activity:** Assess whether your clinicians have the information needed to judge a CDS recommendation. ### Module 5 — Does it perform equally across your patients? Performance assessment across demographic and clinical subgroups. _(55 min)_ **Objectives** - Assess performance across patient subgroups - Identify subgroups where performance degrades - Determine whether degradation is acceptable **Topics:** Subgroup performance · Demographic variation · Clinical subgroups · Acceptability **Activity:** Assess performance across subgroups in your own patient population. ### Module 6 — Where does liability land? Liability allocation between clinician, institution, and vendor, which is genuinely unsettled. _(45 min)_ **Objectives** - Map liability exposure across parties - Identify where the law is unsettled - Manage exposure through documentation and consent **Topics:** Liability allocation · Standard of care · Unsettled law · Exposure management **Activity:** Map liability exposure for one CDS deployment with counsel. ### Module 7 — Why must you validate locally? Local validation before deployment, because vendor performance figures do not transfer. _(50 min)_ **Objectives** - Design local validation - Compare local against vendor-reported performance - Set deployment criteria **Topics:** Local validation design · Performance comparison · Deployment criteria · Ongoing monitoring **Activity:** Design a local validation protocol with explicit deployment criteria. ### Module 8 — Building the validation protocol The workshop module: a complete validation protocol for one CDS use case. _(50 min)_ **Objectives** - Produce a complete validation protocol - Include subgroup analysis - Define stopping criteria **Topics:** Protocol construction · Subgroup analysis · Stopping criteria · Committee review **Activity:** Complete the protocol and present it to a CDS committee for approval. ## What is the capstone project? **Local validation protocol for one CDS use case.** Produce a complete CDS validation protocol: regulatory classification, evidence grounding with citations, an automation bias mitigation design, transparency assessment, subgroup performance analysis on your own population, liability mapping with counsel, and explicit deployment and stopping criteria. _Deliverable:_ A validation protocol approved by a clinical decision support committee. ## How are learners assessed? - Subgroup analysis conducted on the organization's own patient population - Protocol must include stopping criteria that could halt deployment - Liability mapping reviewed by counsel ## What ships with the course? - **Facilitator guide.** Session-by-session running order, discussion prompts, and the questions that reliably derail a room. - **Learner workbook.** Exercises, checklists, and the templates each module's activity produces. - **Hands-on lab environment.** A sandboxed ibl.ai deployment so exercises run against real agents, not screenshots. - **Assessment bank.** Scenario questions and rubric criteria mapped to each stated learning outcome. - **Source bibliography.** Every primary regulation and standard cited on this page, linked and dated. ## Which AI agents does this course use? - [Clinical Support Agent](https://ibl.ai/solutions/medical-healthcare/agent/clinical-support-agent) - [Quality Improvement Agent](https://ibl.ai/solutions/medical-healthcare/agent/quality-improvement-agent) - [Research Agent](https://ibl.ai/solutions/medical-healthcare/agent/research-agent) - [Compliance Training Agent](https://ibl.ai/solutions/medical-healthcare/agent/compliance-training-agent) ## Where does the course material come from? Every module is grounded in primary sources — the regulation, standard, or research itself, not a summary of it. Each was resolved at authoring time. - [HealthIT.gov](https://www.healthit.gov/) — ASTP/ONC. Algorithm transparency requirements for certified health IT. - [AI/ML in Software as a Medical Device](https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device) — FDA. The regulatory boundary analyzed in Module 1. - [Augmented Intelligence in Medicine](https://www.ama-assn.org/practice-management/digital/augmented-intelligence-medicine) — American Medical Association. Physician guidance on CDS use and professional responsibility. - [Agency for Healthcare Research and Quality](https://www.ahrq.gov/) — AHRQ. Patient safety and evidence methodology for the validation design. ## Delivery notes Binding guidance for anyone preparing and delivering this course: - Module 3's automation bias is the safety core. The paradox — that a more reliable system produces more dangerous deference — is counterintuitive and must be demonstrated, not asserted. - Module 5's subgroup analysis must use the organization's own population. Published performance figures from a different population are the standard failure in CDS deployment. - Module 6 must state that liability allocation is unsettled. Any confident answer here is wrong and would mislead institutions making real decisions. - Have both clinical leadership and counsel review the course. The regulatory and liability content is consequential and should not be written by informaticists alone. - Module 8's stopping criteria must be capable of halting a deployment leadership wants. A protocol that cannot say no is a formality. ## Why run AI training on a platform you own? - **You own the course, not a licence to it.** Course content, learner data, and the platform run inside your perimeter — you own all the code and the data. - **Model-agnostic delivery.** Run the course's AI components on any LLM — Claude, GPT, Llama, Gemini, Command — and switch anytime. - **No per-seat training licences.** Usage-based or self-hosted, so cost tracks actual use rather than headcount. - **Deploy anywhere.** Cloud, private VPC, on-premise, or fully air-gapped — including for cohorts that cannot use public AI tools. ## Frequently asked questions ### What does the AI in Clinical Decision Support: Evidence, Limits, and Liability course cover? Clinical decision support sits closest to patient harm and carries the least settled liability. This course covers evidence grounding and citation to primary literature, automation bias as the central risk, algorithm transparency obligations, performance across patient populations, and local validation before deployment. It runs 6 hours across 8 modules across 8 modules, at advanced level, and closes with a capstone: Local validation protocol for one CDS use case. ### Who should take AI in Clinical Decision Support: Evidence, Limits, and Liability? It is written for Chief medical informatics officers, Clinical decision support committees, Physician and nursing leadership, Quality and patient safety officers. Prerequisites: Clinical background or clinical informatics experience; Familiarity with your CDS governance. ### Can we run this course on our own infrastructure? Yes. ibl.ai is model-agnostic and deploy-anywhere — cloud, private VPC, on-premise, or fully air-gapped — and you own all the code and the data. Cohort data, submissions, and any material learners upload stay inside your perimeter, which matters for healthcare teams that cannot send work to a public AI tool. ### How do we get access to AI in Clinical Decision Support: Evidence, Limits, and Liability? Request access and we will set it up for your cohort — hosted by ibl.ai, or running against your own deployment. Tell us the group size and timing you need, and whether it should run inside your own perimeter. ### How much does AI training for healthcare cost on ibl.ai? There is no per-seat pricing — you pay for usage or self-host and pay only for the infrastructure, so a 5,000-person rollout does not cost 5,000 licences. 1.6M+ users across 400+ organizations run the platform this way, including NVIDIA, MIT, and Syracuse University. ## More Healthcare courses - [HIPAA-Compliant AI: PHI, BAAs, and Where the Data Lives](https://ibl.ai/solutions/medical-healthcare/course/hipaa-compliant-ai): What HIPAA actually requires of an AI deployment — the BAA analysis, Security Rule safeguards, minimum necessary, and the architecture that keeps PHI inside your boundary. - [Clinical Documentation with AI: Ambient Notes and Review](https://ibl.ai/solutions/medical-healthcare/course/clinical-documentation-with-ai): Deploy ambient documentation safely — accuracy in clinical language, the attestation requirement, note bloat, and measuring whether it returns clinician time. - [Medical Coding with AI: ICD-10, CPT, and Denial Prevention](https://ibl.ai/solutions/medical-healthcare/course/medical-coding-with-ai): AI-assisted coding that improves accuracy rather than just speed — code suggestion, documentation gap detection, denial prevention, and staying clear of upcoding. - [Prior Authorization Automation with AI Agents](https://ibl.ai/solutions/medical-healthcare/course/prior-authorization-automation): Compress the highest-friction administrative process in healthcare — payer requirement lookup, packet assembly, status tracking, and appeal drafting. - [Patient Education Agents: Health Literacy and Safety](https://ibl.ai/solutions/medical-healthcare/course/patient-education-agents): Patient-facing AI that explains conditions and discharge instructions safely — reading level, language access, scope boundaries, and symptom escalation. - [When Your AI Becomes a Medical Device: FDA and SaMD](https://ibl.ai/solutions/medical-healthcare/course/fda-samd-when-ai-becomes-a-device): The regulatory boundary between clinical software and a regulated device — the CDS exemption, SaMD classification, and what changes when a model updates.